Quality of life and adjuvant tamoxifen treatment in breast cancer patients

Boehm, Daniel; Lebrecht, Antje; Kantelhardt, EJ; Schmidt, Martina; Siggelkow, W.; Kölbl, H.

doi:10.1055/s-0028-1088800

Cited by 8 publications

(8 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The tamoxifen-induced menopause symptoms in breast cancer patients on adjuvant hormonal therapy reflected the results of previous studies which stated that this reduced one's QOL. [ 9 36 ] This study confirmed that the effects of the new normal and inner strength are factors which influence the QOL of breast cancer patients on adjuvant hormonal therapy. In previous studies, when women with chronic health problems including breast cancer, heart disease, or organ transplantation were faced with a difficult and challenging situation, the ability to adapt to and reorganize their lives in lieu of the new normal as promoted by inner strength resulted in enhanced QOL and effective self-management.…”

Section: Discussionsupporting

confidence: 65%

Perceived New Normal and Inner Strength on Quality of Life in Breast Cancer Patients Receiving Adjuvant Endocrine Therapy

Ryu

2021

Asia-Pacific Journal of Oncology Nursing

View full text Add to dashboard Cite

Objective: This study aimed to investigate the differences in symptom experience, inner strength, adherence, and quality of life (QOL) according to the perception of the new normal, and identify the factors related to the QOL of breast cancer patients undergoing adjuvant hormonal therapy based on the theory of inner strength in women. Methods: This cross-sectional study recruited patients with breast cancer receiving adjuvant hormonal therapy in the National Cancer Center. Demographic and clinical characteristics were recorded, and patients were assessed using the M. D. Anderson Symptom Inventory, Connor-Davidson Resilience Scale 2, Morisky Medication Adherence Scale 8, and Functional Assessment of Cancer Therapy-General Scale. Results: After the breast cancer diagnosis, the perception of the new normal showed a significant dependence on pill count and emotional and functional well-being. The hierarchical regression analysis indicated that the new normal, symptom interference, and inner strength after adjusting for age, time since diagnosis, and receiving chemotherapy were significant predictors of QOL in breast cancer patients receiving adjuvant endocrine therapy. The model accounted for 47.8% of the variance in QOL. Conclusions: The theory of inner strength might be a potential pathway in health care to improve patients' QOL during long-term medication. The results of this study have both theoretical and applied implications. The findings can be utilized as evidence for developing an effective intervention that improves the QOL and adherence to adjuvant hormonal therapy of breast cancer patients.

show abstract

Section: Discussionsupporting

confidence: 65%

Perceived New Normal and Inner Strength on Quality of Life in Breast Cancer Patients Receiving Adjuvant Endocrine Therapy

Ryu

2021

Asia-Pacific Journal of Oncology Nursing

View full text Add to dashboard Cite

show abstract

“…As the centrality indices show, the most important item for this network is the concern that endocrine therapy disrupts one's life. Other data show that 43.4% of patients report a disruption of daily activity [33], which is most prevalent in the first 3 months of endocrine therapy [34]. Interventions aiming at improving treatment expectations about endocrine therapy should target the patients' idea of the harmfulness of endocrine therapy and enhanced coping expectations by providing coping strategies.…”

Section: Discussion Of Resultsmentioning

confidence: 99%

What do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy

et al. 2016

View full text Add to dashboard Cite

Negative treatment expectations before treatment start are mainly associated with psychological variables. These results are relevant for patient education in clinical settings. To improve expectations, clinicians might emphasize treatment efficacy and discuss general and specific medication concerns. Improving treatment knowledge could also be beneficial. Copyright © 2016 John Wiley & Sons, Ltd.

show abstract

“…This finding, which was also unique, may have reflected side-effects of anti-hormone therapy, which can impair physical functioning. 28) Therefore, women who are being treated currently with anti-hormone therapy may need to increase their PA in order to overcome the physical burden. Also, it is possible that they received information concerning the importance of PA for prevention of osteoporosis from their health care providers.…”

Section: Discussionmentioning

confidence: 99%

Associations between Health Behaviors and Health-Related Quality of Life among Breast Cancer Survivors

Kim

Yun

2012

Asian Oncol Nurs

View full text Add to dashboard Cite

Purpose:To examine the levels of physical activity (PA) and diet quality, socio-demographic and clinical correlates, and identify associations with health-related quality of life (HRQOL) among breast cancer survivors. Methods: The study used a cross-sectional study design. A total of 74 breast cancer survivors who had completed their primary cancer therapy were recruited from a comprehensive cancer center in Korea. Measurements used included the International Physical Activity Questionnaire, the Diet Quality Index, and the EORTC QLQ-C30. Results: Only twenty-six women (35.1%) met the American Cancer Society criteria of weekly PA, while most participants (93.2%) displayed good or excellent diet quality. Those less likely to meet the PA criteria were older women, women who had a lower economic level, and women not receiving anti-hormone therapy. However, there was no significant factor associated with diet quality. Women who met the criteria for PA displayed significantly better global QOL than women who did not meet the criteria. No significant differences were found in HRQOL between women who did and did not meet the diet quality criteria. Conclusion: Nurses should be aware of breast cancer survivors who are older and who have a low economic status when assessing and screening the level of PA to improve HRQOL.

show abstract

Quality of life and adjuvant tamoxifen treatment in breast cancer patients

Cited by 8 publications

References 0 publications

Perceived New Normal and Inner Strength on Quality of Life in Breast Cancer Patients Receiving Adjuvant Endocrine Therapy

Perceived New Normal and Inner Strength on Quality of Life in Breast Cancer Patients Receiving Adjuvant Endocrine Therapy

What do women with breast cancer expect from their treatment? Correlates of negative treatment expectations about endocrine therapy

Associations between Health Behaviors and Health-Related Quality of Life among Breast Cancer Survivors

Contact Info

Product

Resources

About